Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study

Lipids in Health and Disease Xing et al. Lipids in Health and Disease (2025) 24:345 https://doi.org/10.1186/s12944-025-02777-2 Open Access CO R R E C T I O N Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study Xiaoxuan Xing1, Zhizhou Wang1, Ke Wang1, Yiming Hua1, Xiaoxi Li1, Kejia Le2, Wenbing Ma3, Yingyun Guan4, Aiping Deng5, Xiong Yun6, Hongfu Cai7, Yongning Lyu8, Guoying Xiong9, Min Yang10, Siyang Wang11, Chaojun Xue12, Jing Zhang13, Qiushi Guo14, Song Hu15, Jing Li16, Xianzhe Dong1* and Lan Zhang1* Correction: Lipids in Health and Disease 24, 248 (2025) https://doi.org/10.1186/s12944-025-02673-9 Following publication of the original article [1], the authors reported an incorrect statement on page 5, 3rd paragraph under section “Safety outcomes after PS matching”. The statement currently reads: “With regard to hyperglycemia, proportion of patients with FPG increase and new-onset diabetes were lower than the generic group…”. The original article can be found online at https://doi.org/10.1186/s1 2944-025-02673-9. *Correspondence: Xianzhe Dong Lan Zhang 1 Department of Pharmacy, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Xicheng District, Beijing 100053, China 2 Department of Pharmacy, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China 3 Department of Pharmacy, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China 4 Department of Pharmacy, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China 5 Department of Pharmacy, The Central Hospital of Wuhan, Wuhan, China The statement should read: “With regard to hyperglycemia, proportion of patients with FPG increase and new-onset diabetes were lower in the generic group…”. The original article [1] has been corrected. 6 Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China 7 Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China 8 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 9 Department of Pharmacy, Nanchang First Hospital, Nanchang, China 10 Department of Pharmacy, Xi’an Central Hospital, Xi’an, China 11 Department of Pharmacy, The Second Hospital of Shanxi Medical University, Taiyuan, China 12 Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China 13 Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China 14 Pharmacy Department, First Hospital of Jilin University-The Eastern Division, Changchun, China 15 Department of Pharmacy, Wuhan No.1 Hospital, Wuhan, China 16 Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China © The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creati vecommons.org/licenses/by-nc-nd/4.0/. Xing et al. Lipids in Health and Disease (2025) 24:345 References 1. Xing X, Wang Z, Wang K, et al. Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin u Page 2 of 2  (...truncated)